glp-1 drugs alzheimer's failed to slow in two big clinical trials Could GLP‑1 Weight‑Loss Drugs Help

FIGURE 1 Complex I (cI) is an NADH-ubiquinone oxidoreductase that pumps four protons into the intermembrane space (IMS) upon each NADH oxidation

Say goodbye to dry, bumpy, and tired-looking skin

In vivo experiments Experiments involving animals were approved by the Italian Ministry of Health and have been done in accordance with the applicable Italian laws (D.L.vo 26/14 and following amendments), the Institutional Animal Care and Use Committee, and the institutional guidelines at the European Institute of Oncology

At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits